jizz国产,永久免费的啪啪免费网址,国产精品一二三级,欧美精品在线视频观看

  設(shè)為主頁(yè) 加入收藏 English
 
 
 
 新聞動(dòng)態(tài)
 行業(yè)動(dòng)態(tài)
 展會(huì)信息
 誠(chéng)聘英才
 
 

測(cè)量應(yīng)用案例-20220504

發(fā)布時(shí)間:2022-05-13  點(diǎn)擊次數(shù):283  新聞來(lái)源:
 

文獻(xiàn)名: A biotin-avidin-system-based virus-mimicking nanovaccine for tumor immunotherapy

 

 

作者 Zhuoxuan LuabYanwei Zhanga,Yi Wanga,Guang-Hong Tana,Feng-Ying Huanga,Rong Caoa,Nongyue Heb,Liming Zhangab

a Key Laboratory of Tropical Translational Medicine of Ministry of Education & Hainan Provincial Key Laboratory of Tropical Medicine, Hainan Medical University, Haikou 571199, PR China

b State Key Laboratory of Bioelectronics, School of Biological Science and Medical Engineering, Southeast University, Nanjing 210096, PR China

 

 

 

摘要:Virus is a nanosized pathogen and mainly composed of viral protein and nucleic acids. Under the pressure of long-term selection, mammals have gradually evolved effective immune mechanisms to defend themselves against viruses. In addition to recognizing viral proteins, immune system can also respond to viral sequence-specific nucleic acids, including CpG ODN, single- and double- strand RNA, and thereby enhancing the ability to remove infected viruses. Inspired by these immune mechanisms, we have attempted to develop a tracing virus-mimicking nanovaccine for tumor immunotherapy. This nanovaccine mainly consists of nucleic acids (CpG ODN), proteins (including tumor-associated antigen, and neutravidin (nAvidin) as skeleton materials for constructing nanovaccine and carriers for loading tumor-associated antigen and CpG ODN), and the dye molecules for assembling nAvidin to form nanoparticles comparable in size to viruses and tracing the vaccine in vitro and in vivo. The as-prepared nanovaccine efficiently induces the maturation of dendritic cell, the enhancement of antigen cross-presentation ability, and amplification of cytokine production in vitro. Furthermore, in vivo analysis clearly shows that it targets lymph nodes, successfully presents antigens to generate tumor-antigen-specific CD8+ T cells and induces a Th1-biased immune response. Most notably, this virus-mimicking nanovaccine significantly inhibits the growth of antigen-expressed tumor and prolongs the survival time of the antigen-expressed tumor bearing mice.

 

關(guān)鍵詞:NanovaccineBiotin-avidin system,Fluorescence imagingTargeting lymph nodes,Anti-tumor performance

 
 
上海市普陀區(qū)嵐皋路567號(hào)1108-26室 電話:021-62665073 400-718-7758 傳真:021-62761957 聯(lián)系郵箱:info@bicchina.com
美國(guó)布魯克海文儀器公司上海代表處 版權(quán)所有  管理登陸 ICP備案號(hào):滬ICP備19006074號(hào)-2 技術(shù)支持:化工儀器網(wǎng)